PTSM: Pharmaceutical Technology Sourcing and Management, Apr 30, 2007 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

PTSM: Pharmaceutical Technology Sourcing and Management, Apr 30, 2007
Global Feature
Pharmaceutical Benchmarking: A Contract Manufacturing Perspective
By Shane Ernst
The author analyzes the study design, participation, and data pooling from a recent benchmarking study on pharmaceutical manufacturing and raises concerns about the process used and data collected in evaluating the performance of contract manufacturers.
Pharma Partner Focus
Ricerca Unveils Growth Strategy
By Patricia Van Arnum
Ricerca Biosciences LLC a contract drug-development company, is embarking on a growth strategy upon which it hopes to double its revenues by 2009. The company recently completed a financial restructuring that includes new equity and term facilities totaling nearly $50 million. That financing will enable Ricerca to implement a multiyear business plan, which includes a $15-million investment to add chemistry and biological laboratories to its site in Concord, Ohio.
Outsourcing
Project Managers in the Spotlight
By Jim Miller
Strong demand is straining service providers' project-management capabilities; Patheon receives a much-needed cash infusion.
News
Agreements and contracts
The latest pacts from the pharmaceutical supply chain.
Regulatory and association news
The latest regulatory and association news for pharmaceutical manufacturers and contract manufacturing organizations.
People
People on the move.
Mergers, acquisitions, and restructuring
A roundup of company moves and positioning from the pharmaceutical industry and biotechnology industries and contract service providers.
Expansions
A roundup of manufacturing and service expansions for April 2007.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Click here